Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$17.64 - $39.57 $754,992 - $1.69 Million
-42,800 Reduced 73.67%
15,300 $412,000
Q4 2021

Feb 15, 2022

SELL
$34.2 - $47.56 $266,760 - $370,968
-7,800 Reduced 11.84%
58,100 $2.15 Million
Q3 2021

Nov 16, 2021

BUY
$27.88 - $58.25 $507,416 - $1.06 Million
18,200 Added 38.16%
65,900 $3.15 Million
Q2 2021

Aug 16, 2021

SELL
$25.79 - $42.11 $275,953 - $450,577
-10,700 Reduced 18.32%
47,700 $1.61 Million
Q1 2021

May 18, 2021

SELL
$38.75 - $86.92 $2.88 Million - $6.47 Million
-74,400 Reduced 56.02%
58,400 $2.41 Million
Q4 2020

Feb 17, 2021

BUY
$34.61 - $123.66 $1.63 Million - $5.82 Million
47,100 Added 54.96%
132,800 $5.76 Million
Q3 2020

Nov 17, 2020

BUY
$37.49 - $63.19 $671,071 - $1.13 Million
17,900 Added 26.4%
85,700 $3.68 Million
Q2 2020

Aug 17, 2020

BUY
$12.66 - $58.27 $858,348 - $3.95 Million
67,800 New
67,800 $3.17 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.